医学
胫骨高位截骨术
骨不连
截骨术
骨关节炎
外科
胫骨
负重
膝关节
病理
替代医学
作者
Ryohei Takeuchi,Hiroyuki Ishikawa,Ken Kumagai,Yuichiro Yamaguchi,Naoki Chiba,Yasushi Akamatsu,Tomoyuki Saito
出处
期刊:Arthroscopy
[Elsevier BV]
日期:2011-10-10
卷期号:28 (1): 85-94
被引量:333
标识
DOI:10.1016/j.arthro.2011.06.034
摘要
Purpose The purpose of this study was to determine the frequency of lateral hinge fractures after opening‐wedge high tibial osteotomy and investigate the patterns of fracture and their clinical outcome. Methods We analyzed 104 knees in 93 patients with a mean age of 68 ± 7 years. Of the knees, 74 were diagnosed as having primary osteoarthritis and 30 with osteonecrosis. The mean follow‐up period was 41 months. Lateral hinge fractures were classified as follows: type I, the fracture reaches just proximal to or within the tibiofibular joint; type II, the fracture reaches the distal portion of the proximal tibiofibular joint; and type III, a lateral plateau fracture. A standard postoperative rehabilitation protocol was used for type I fractures, 3 of 5 patients with type II fractures were treated with non–weight bearing, and type III fractures were treated with non–weight bearing until visible callus formation. Results The Knee Society scores for the knee and for function showed improvement from 49 ± 11 to 91 ± 7.7 points and from 62 ± 13 to 95 ± 8.2 points, respectively. Lateral cortex fractures were observed in 26 knees (25%): 19 type I, 5 type II, and 2 type III. In the type II fracture group, 2 of 5 patients were judged to have a delayed bone union. There were 2 cases of infection (2%) and 1 case of traumatic neuroma (1%) but no instances of implant failure, nonunion, or deep vein thrombosis among our patient cohort. Conclusions High tibial osteotomy patients treated with a combination of TomoFix (Synthes, Bettlach, Switzerland) and bone substitute were able to walk with full weight bearing 2 weeks after surgery. No complications were seen in 19 patients with type I fractures. Of 5 patients with type II fractures, 2 had delayed unions with a correction loss of 3° and 7°, respectively. Level of Evidence Level IV, therapeutic case series.
科研通智能强力驱动
Strongly Powered by AbleSci AI